147 related articles for article (PubMed ID: 11790786)
21. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A; Kolkenbrock H; Tschesche H
FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor.
Maquoi E; Noël A; Frankenne F; Angliker H; Murphy G; Foidart JM
FEBS Lett; 1998 Mar; 424(3):262-6. PubMed ID: 9539163
[TBL] [Abstract][Full Text] [Related]
23. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.
Olson MW; Gervasi DC; Mobashery S; Fridman R
J Biol Chem; 1997 Nov; 272(47):29975-83. PubMed ID: 9368077
[TBL] [Abstract][Full Text] [Related]
25. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
26. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
27. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
28. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
29. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C
J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657
[TBL] [Abstract][Full Text] [Related]
30. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
[TBL] [Abstract][Full Text] [Related]
31. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
32. The gelatinases and their inhibitors: the structure-activity relationships.
Swarnakar S; Mishra A; Chaudhuri SR
Exp Suppl; 2012; 103():57-82. PubMed ID: 22642190
[TBL] [Abstract][Full Text] [Related]
33. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
34. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
35. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
Nawrocki B; Polette M; Burlet H; Birembaut P; Adnet JJ
J Bone Miner Res; 1999 Feb; 14(2):288-94. PubMed ID: 9933484
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
[TBL] [Abstract][Full Text] [Related]
37. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
38. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.
English WR; Holtz B; Vogt G; Knäuper V; Murphy G
J Biol Chem; 2001 Nov; 276(45):42018-26. PubMed ID: 11555661
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
